(BBU) Brookfield Business Partners - Overview
Stock: Business Services, Infrastructure Services, Construction, Energy, Industrials
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.91% |
| Yield on Cost 5y | 0.98% |
| Yield CAGR 5y | -0.10% |
| Payout Consistency | 95.6% |
| Payout Ratio | 16.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.8% |
| Relative Tail Risk | -7.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.31 |
| Alpha | 47.70 |
| Character TTM | |
|---|---|
| Beta | 1.218 |
| Beta Downside | 1.463 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.28% |
| CAGR/Max DD | 0.68 |
Description: BBU Brookfield Business Partners January 13, 2026
Brookfield Business Partners L.P. (BBU) is a Bermuda-incorporated private-equity platform that targets majority-controlled investments in growth-oriented businesses across business services, infrastructure, construction, energy, and industrial sectors worldwide, aiming for 15%-20% internal rates of return. Founded in 2016 as a subsidiary of Brookfield Corporation, the firm typically provides growth capital, facilitates divestitures, and executes acquisitions, favoring global exposure and controlling stakes.
As of the latest filing, BBU reported a portfolio EBITDA of roughly $2.3 billion and a dividend yield near 5%, reflecting its cash-generating assets in fee-based infrastructure and long-term contracts. The construction and engineering segment is sensitive to global capex cycles, with U.S. and European infrastructure spending projected to grow 3-4% annually through 2028, supporting BBU’s pipeline. Additionally, the firm’s exposure to renewable-energy assets aligns with the sector’s 10%-12% annual capacity-addition rate, offering a hedge against fossil-fuel volatility.
For a deeper, data-driven assessment of BBU’s valuation metrics and scenario analysis, you might explore the analytics platform ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -13.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.59 > 1.0 |
| NWC/Revenue: 46.48% < 20% (prev -3.56%; Δ 50.03% < -1%) |
| CFO/TA 0.05 > 3% & CFO 3.53b > Net Income -13.6m |
| Net Debt (40.13b) to EBITDA (5.94b): 6.75 < 3 |
| Current Ratio: 1.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (88.3m) vs 12m ago -59.30% < -2% |
| Gross Margin: 19.33% > 18% (prev 0.14%; Δ 1919 % > 0.5%) |
| Asset Turnover: 36.49% > 50% (prev 53.82%; Δ -17.33% > 0%) |
| Interest Coverage Ratio: 1.17 > 6 (EBITDA TTM 5.94b / Interest Expense TTM 3.16b) |
Altman Z'' 1.50
| A: 0.17 (Total Current Assets 28.30b - Total Current Liabilities 15.48b) / Total Assets 75.62b |
| B: 0.01 (Retained Earnings 462.5m / Total Assets 75.62b) |
| C: 0.05 (EBIT TTM 3.70b / Avg Total Assets 75.55b) |
| D: 0.04 (Book Value of Equity 2.29b / Total Liabilities 60.34b) |
| Altman-Z'' Score: 1.50 = BB |
Beneish M -3.02
| DSRI: 1.81 (Receivables 7.71b/6.28b, Revenue 27.57b/40.62b) |
| GMI: 0.73 (GM 19.33% / 14.12%) |
| AQI: 0.77 (AQ_t 0.48 / AQ_t-1 0.62) |
| SGI: 0.68 (Revenue 27.57b / 40.62b) |
| TATA: -0.05 (NI -13.6m - CFO 3.53b) / TA 75.62b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of BBU shares?
Over the past week, the price has changed by +1.46%, over one month by +6.85%, over three months by +16.63% and over the past year by +61.15%.
Is BBU a buy, sell or hold?
- StrongBuy: 0
- Buy: 5
- Hold: 0
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the BBU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.2 | 9.1% |
| Analysts Target Price | 40.2 | 9.1% |
| ValueRay Target Price | 41 | 11.3% |
BBU Fundamental Data Overview February 09, 2026
P/S = 0.1165
P/B = 1.3947
P/EG = -0.5
Revenue TTM = 27.57b USD
EBIT TTM = 3.70b USD
EBITDA TTM = 5.94b USD
Long Term Debt = 42.42b USD (from longTermDebt, last quarter)
Short Term Debt = 1.32b USD (from shortTermDebt, last quarter)
Debt = 43.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 40.13b USD (from netDebt column, last quarter)
Enterprise Value = 43.32b USD (3.20b + Debt 43.67b - CCE 3.55b)
Interest Coverage Ratio = 1.17 (Ebit TTM 3.70b / Interest Expense TTM 3.16b)
EV/FCF = 30.20x (Enterprise Value 43.32b / FCF TTM 1.43b)
FCF Yield = 3.31% (FCF TTM 1.43b / Enterprise Value 43.32b)
FCF Margin = 5.20% (FCF TTM 1.43b / Revenue TTM 27.57b)
Net Margin = -0.05% (Net Income TTM -13.6m / Revenue TTM 27.57b)
Gross Margin = 19.33% ((Revenue TTM 27.57b - Cost of Revenue TTM 22.24b) / Revenue TTM)
Gross Margin QoQ = 20.76% (prev 18.15%)
Tobins Q-Ratio = 0.57 (Enterprise Value 43.32b / Total Assets 75.62b)
Interest Expense / Debt = 1.82% (Interest Expense 796.1m / Debt 43.67b)
Taxrate = 32.95% (58.9m / 178.7m)
NOPAT = 2.48b (EBIT 3.70b * (1 - 32.95%))
Current Ratio = 1.83 (Total Current Assets 28.30b / Total Current Liabilities 15.48b)
Debt / Equity = 19.07 (Debt 43.67b / totalStockholderEquity, last quarter 2.29b)
Debt / EBITDA = 6.75 (Net Debt 40.13b / EBITDA 5.94b)
Debt / FCF = 27.97 (Net Debt 40.13b / FCF TTM 1.43b)
Total Stockholder Equity = 2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.02% (Net Income -13.6m / Total Assets 75.62b)
RoE = -0.60% (Net Income TTM -13.6m / Total Stockholder Equity 2.27b)
RoCE = 8.27% (EBIT 3.70b / Capital Employed (Equity 2.27b + L.T.Debt 42.42b))
RoIC = 5.42% (NOPAT 2.48b / Invested Capital 45.68b)
WACC = 1.85% (E(3.20b)/V(46.87b) * Re(10.40%) + D(43.67b)/V(46.87b) * Rd(1.82%) * (1-Tc(0.33)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.87%
[DCF Debug] Terminal Value 81.23% ; FCFF base≈953.1m ; Y1≈641.3m ; Y5≈307.4m
Fair Price DCF = N/A (negative equity: EV 9.75b - Net Debt 40.13b = -30.38b; debt exceeds intrinsic value)
EPS Correlation: -9.21 | EPS CAGR: -5.08% | SUE: -0.66 | # QB: 0
Revenue Correlation: -90.04 | Revenue CAGR: -15.30% | SUE: 1.80 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.36 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=1.74 | Chg30d=+1.870 | Revisions Net=-1 | Growth EPS=+0.0% | Growth Revenue=+0.0%
EPS next Year (2027-12-31): EPS=2.42 | Chg30d=+1.840 | Revisions Net=+0 | Growth EPS=+39.1% | Growth Revenue=+2.2%